14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.760 2 days ( -0.175 % )
Last Price $234.47 0.175 %
High/ Low $234.16 - $240.00 4.10%
Chg 7 Days 1.16 % $231.78 $234.47
Chg 30 Days -1.44 % $237.90 $234.47
Chg 12 mos 2.71 % $228.29 $234.47
Trend - 3 mos 11.84 % Width: 12.42 %
Trend - 12 mos 3.36 % Width: 22.32 %
Pred. range - 3 mos $261.62 - $294.12 11.58 % - 25.44 %
Pred. range - 12 mos $219.65 - $268.67 -6.32 % - 14.59 %
Short MA avg 3 mos Sell Apr 19, 2024 - 3 days
Long MA avg 3 mos Sell Apr 19, 2024 - 3 days
Short/Long MA avg 3 mos Sell Apr 15, 2024 - 7 days
Short MA avg 12 mos Sell Apr 19, 2024 - 3 days
Long MA avg 12 mos Sell Mar 28, 2024 - 18 days
Short/Long MA avg 12 mos Buy Mar 11, 2024 - 31 days
Pivot Short Buy Mar 11, 2024 - 31 days
Bollinger Buy Mar 12, 2024 - 30 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About United Therapeutics Corporation

United Therapeutics United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin a... UTHR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT